Results 161 to 170 of about 9,532 (171)

Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2020
Giovanni Palladini, Giampaolo Merlini, Mario Nuvolone   +2 more
exaly  

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

Blood, 2011
Shaji K Kumar, Angela Dispenzieri, Morie A Gertz   +2 more
exaly  

Pomalidomide: Evaluation of cytochrome P450 and transporter-mediated drug–drug interaction potential in vitro and in healthy subjects

Journal of Clinical Pharmacology, 2015
Maria Palmisano, Gondi Kumar
exaly  

A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer

European Journal of Cancer, 2011
Colin Weekes, Suzanne Jones, Johanna C Bendell   +2 more
exaly  

Enhanced cross-priming of naive CD8+ T cells by dendritic cells treated by the IMiDs® immunomodulatory compounds lenalidomide and pomalidomide

Immunology, 2013
Christine Galustian, Marie-Christine Labarthe   +1 more
exaly  

Pomalidomid

2019
Weisel, Katja, Wörmann, Bernhard, Goldschmidt, Hartmut, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Deutschland. Gemeinsamer Bundesausschuss, Scheid, Christof, Röllig, Christoph   +6 more
openaire   +1 more source

Modest activity of pomalidomide in patients with myelofibrosis and significant anemia

Leukemia Research, 2013
Naval Daver, Alfonso Quintás-Cardama
exaly  

Effect of Renal and Hepatic Function on Pomalidomide Dose in Patients with Relapsed/Refractory Multiple Myeloma

Blood, 2014
Tomer M Mark, David Jayabalan, Morton Coleman   +2 more
exaly  

Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN

British Journal of Haematology, 2014
Anita K Gandhi, Hiroshi Handa, Peter H Schafer   +2 more
exaly  

Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma

Blood Cancer Journal, 2013
Shaji K Kumar, Angela Dispenzieri, Sundararajan Vincent Rajkumar   +2 more
exaly